• news-banner

    Expert Insights

What can UK investors interested in Life Sciences learn from their more experienced, including US, counterparts?

min read

The recent tie-up between Canary Wharf and Kadans demonstrates the enthusiasm of traditional UK RE investors and developers to access the lucrative life sciences market. By partnering with an experienced developer in the sector, Canary Wharf will benefit from in-depth sector knowledge gained by Kadans over many years of developing lab space, firstly overseas and more latterly in the UK market. So, what are the benefits to UK investors/developers looking to their overseas counterparts for guidance, best practice examples and a partnership to assist them in making the most of the opportunity that the growth in this market presents in the UK?

Whilst occupier demand is currently booming, and the life sciences sector is highly competitive to enter from a developer perspective. Not only is the land in the right location difficult to come by and expensive but building lab-capable space is much more expensive than an office building of the same internal area. Therefore, it is critical that the right decisions are made early on about how the buildings are designed and fitted out. An experienced life sciences developer or operator of laboratories already knows and understands the tenant market and the unique requirements of lab space. They see that re-purposing of existing stock is often a non-starter if the intention is for the building to be fitted as laboratories or at least “lab-capable” unless the fundamentals of the building already work.

Likewise, a life science developer knows how to design new buildings to make the best use of the available space. Any floors in the building will need a higher floor-to-ceiling height than an office would. Laboratories need increased utilities capacity to support all of the equipment likely to be required, including backup generators. Most lab spaces will need easy and secure access to chemical storage and sufficient loading bays and transport lifts. The experienced developer knows the types of equipment that will likely be needed by its eventual tenants, how much electricity they might use and what the tenant fit-out may look like. They may already know and work with an experienced team of professionals who know how to design and build the space.

A further benefit may be the existing relationships that an established life sciences developer has, perhaps in other areas of the country or even other jurisdictions. Life sciences is an international sector – you only have to look at the breadth of companies developing covid 19 vaccines to appreciate that.

Many established life sciences and pharmaceutical companies in the US, for example, will have little or no experience in the UK property market. This is where an established developer, perhaps in partnership with a UK entity, can add value to prospective tenants. Guiding them through the process of taking their first UK premises, from finding the right location, ensuring the premises are going to be suitable for the particular requirements of that tenant, making introductions to local professionals with sector knowledge and generally assisting with making a move to a new jurisdiction as smooth as possible.

From the perspective of the life sciences developer, why might they need their inexperienced UK counterpart? The simple answer may be that the UK entity has land and local market knowledge, perhaps including relationships with the all-important local planning authorities. A UK investor/developer with an established reputation and a track record of delivery may be favoured in competitive tender scenarios, which could be the difference between winning or losing a pitch.

It is going to be very interesting to see whether the Kadans and Canary Wharf partnership is a new model for life sciences development in the UK market. The opportunities in the market are clear for those that can combine the right sector development expertise with local knowledge and access to or existing ownership of land in the right location. The benefits to each side are clear, and we might expect to see more tie-ups like this in the coming months.


Written by Louise Ward. 

An original version of this article was first published on EG on 16 May 2022. For more information, please contact Louise Ward or your usual Charles Russell Speechlys contact. 

 

Our thinking

  • Getting The Most From Your People

    Megan Paul

    Events

    min read
  • London Arbitration Week: ‘Building Data Centres Without Building Disputes’

    Gareth Mills

    Events

    min read
  • Construction Market Update: Looking Forward

    Michael O'Connor

    Events

  • Should You Even Bother? Making the Case for Bringing a Case

    Caroline Greenwell

    Events

    min read
  • Britain wants nuclear: Can we build it at pace?

    Kevin Gibbs

    Events

    min read
  • After the Confetti: Why the Real Work Begins the Day After Listing

    Greg Stonefield

    Insights

    min read
  • Investors’ Chronicle quotes Tamasin Perkins on how to avoid invalidating a will

    Tamasin Perkins

    In the Press

    min read
  • Ready for 2027: Legal Developments Shaping the Living Sector in England

    Mark White

    Insights

    min read
  • Q&A: Right to manage: can a landlord object on procedural grounds?

    Lauren Fraser

    Insights

    min read
  • Investing in London Real Estate Seminar

    Chiara Del Frate

    Events

    min read
  • Beds, Meds and Sheds: the beds haven’t gone – they’ve moved into houses

    Mark White

    Insights

    min read
  • Charles Russell Speechlys advises longstanding client SaxaVord Spaceport on its £30m investment from the UK government

    Charlie Ring

    News

    min read
  • Q&A: Recovering a freehold

    Sylwia Barchus

    Insights

    min read
  • Evidencing oral agreements: the weight of words

    Ben Moore

    Insights

    min read
  • Budget 2026: what the energy measures mean for generators, industry and investors

    Kevin Gibbs

    Insights

    min read
  • Nicola Saccardo comments on Italy’s proposed exit tax regime for wealthy individuals in The Daily Telegraph

    Nicola Saccardo

    In the Press

    min read
  • Loss of bargain on contract cancellation: no repudiatory breach required

    Mary Barrett-Jones

    Insights

    min read
  • ICLG quotes Dewdney William Drew on the High Court’s PINK trade mark ruling

    Dewdney William Drew

    In the Press

    min read
  • Amy Shuttleworth and Nicholas Wyatt write in RICS Property Journal about electric vehicle charging point leases

    Amy Shuttleworth

    In the Press

    min read
  • The Law Society Gazette quotes Kerry Stares on the development of the AI-powered Pro Bono Family Justice Hub

    Kerry Stares

    In the Press

    min read
Back to top